including new options like Zepbound. We hope this will spark more meaningful conversations between patients and health care ...
The Food and Drug ... calorie diet and increased physical activity, the FDA noted in a release. An estimated 80 million patients in the U.S. experience the disease, according to Eli Lilly.
Eli Lilly's obesity drug Mounjaro will be available through Britain's state health system for some patients from March, after ...
The mega-blockbuster weight loss GLP-1 drug is now also approved to treat obstructive sleep apnea in adults with obesity, in ...
The stock of the pharmaceutical company, Lupin is quoting higher for the sixth straight trading day; it has rallied 10 per ...